New monoclonal antibodies targeting ACE2 receptor could treat the next waves of SARS-CoV-2
Research led by Rockefeller University in New York investigated alternate targets for monoclonal antibodies to combat SARS-CoV-2 infections.
from Medical Xpress - latest medical and health news stories https://ift.tt/8wcJFgj